The Korea Ministry of Industry, Trade and Industry recently released the second phase (2014-2018) of the basic plan for intelligent robots, which will provide a blueprint for the future development of the robot industry in Korea. The basic plan proposes four areas, including improving the research and development capabilities of robots, promoting robots in various industries, creating an open robotic industry chain, and building a robotic industry integration system. In particular, it proposes research and development of robotic health facilities. The deep integration of the medical and robotics industries has become an important feature of the Korean robot industry. With the cooperation of the government, enterprises and research departments, the Korean medical robot market is booming. In 2010, the Korean government set the medical robot as a national policy issue, and invested 100 billion won (1 yuan to about 164.4 won) to support the development of the medical robot industry. One of the main achievements was the artificial joint replacement surgery robot in Korea. Traditionally, artificial joint replacement surgery uses artificial joints made of metal or ceramic to replace the damaged knee joint, and then the doctor corrects the human bone like a sculptor to make it suitable for artificial joints. The accuracy of the procedure is high, otherwise it may cause more severe pain in the joints. And now this work can be handed over to the robot to complete. The integration of biochemistry and nanotechnology has also created conditions for the development of micromedical robots. At the end of 2013, Korea’s Ministry of Science and Technology of the Future announced that the Institute of Bacterial Robotics at the National University of South Korea has developed the world’s first “in vivo doctor†to treat cancer – nano-robots for colorectal cancer, breast cancer, stomach cancer and liver cancer. High-risk cancer for diagnosis and treatment. It is reported that the robot is 3 microns long and consists of two parts, bacteria and micro-structure containing drugs. It has been successfully tested on animals. When the robot finds the onset of cancer through the flagella, its microstructure will rupture, releasing anticancer agents to the surface of cancer cells. Hyundai Heavy Industries Co., Ltd. is also working with Seoul Lushan Hospital to promote the development of various medical robots. The goal is to develop a variety of medical robots such as orthopedic robots, ligament repair robots, and interventional robots. With the booming medical robot technology in Korea, the use of medical robots for surgery has become the first choice for many patients. "Now 90% of the patients in our department need surgery to choose robots for surgery." Bai Zhiqin, a professor of obstetrics and gynaecology at the Asian University Hospital of Korea, introduced the acceptance of medical robots at a research meeting. Bai Zhiqin said that the advantage of medical robots is that doctors and patients are under less stress. All kinds of diseases can get the best treatment results through medical robot surgery, and both hands can be operated at the same time. According to statistics, there are now 40 Da Vinci medical robot systems in Korea, and experts in various fields have also disclosed their surgical procedures and videos to the medical community. Due to the solid foundation of Korean surgical robot technology, nearly 2,000 medical personnel from 28 countries have come to Korea for training. Korean medical professionals point out that the biggest obstacle to promoting robotic surgery is still the cost issue, because robot surgery costs twice as much as traditional surgery. The emergence of various medical robots in Korea shows the rapid development of science and technology and greatly improves the medical level. Due to the precision of the robot, many parts of the past that are difficult to perform surgery can now be operated by robots. Various diagnostic imaging materials and simulation scenes also facilitate accurate surgery, and remote surgery will become a reality in the future. With the implementation of the second phase of the Korean Intelligent Robot Basic Plan, the future development potential of the medical robot industry in Korea cannot be underestimated.
We are a professional peptide product manufacturer with productive factory, which is able to produce API and petide product intermediate with reliable quality and good price.
Our advantage peptide products:
Custom Peptide modification
Custom Peptides / Peptides Synthesis
Generic Peptides API
Pharmaceutical Peptide
Comstic Peptides
Special Amino Acids
Reaent for Peptides
Most of our products meet EP and USP standards, can be widely used in biochemical Research,Immunology, Histology and as Active Pharmaceutical Ingredients (API).With more than 20 experienced R&D technicians, who with over 10 years experience in peptide chemistry and other related research areas; one R&D center and one GMP standard workshop.
Welcome to contact us.
Generic Peptide APIS,Cosmetic Peptides,GMP Peptides,Custom Peptides,Peptide Synthesis Pharmaceutical Peptides Taizhou Volsen Chemical Co., Ltd. , https://www.volsenchem.com